Results

Total Results: 559 records

Showing results for "resistance".

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
    April 01, 2012 - PULMONARY with "Discussions" in Exec Summary AHRQ Healthcare Horizon Scanning System – Potential High Impact Interventions Report Priority Area 13: Pulmonary Disease including Asthma Potential High Impact Interventions Report Prepared for: Agency for Healthcare Research and Quality U.S. Departmen…
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0398_06-17-2008.pdf
    January 01, 2008 - subgroups of hemodialysis patients treated with erythropoiesis stimulating agents (ESA), or with ESA resistance
  3. effectivehealthcare-admin.ahrq.gov/products/mhs4-opioid-stewardship/rapid-research
    December 01, 2023 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  4. effectivehealthcare-admin.ahrq.gov/products/mhs4-computerized-cds/rapid-research
    February 01, 2024 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  5. effectivehealthcare-admin.ahrq.gov/products/c-difficile-future/research
    December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/healthcare-infections_research-protocol.pdf
    January 01, 2014 - ECRI_Penn EPC FINAL Environ Cleaning Protocol 08_21_14 CC[1] Source: www.effectivehealthcare.ahrq.gov Published online: August 25. 2014 Evidence-based Practice Center Technical Brief Protocol Project Title: Environmental Cleaning for the Prevention of Healthcare-Associated Infections (HAI) I. Background …
  7. effectivehealthcare-admin.ahrq.gov/products/patient-safety-telehealth/research
    September 01, 2023 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fiber-intake-draft-report-appendix-a-b.pdf
    February 25, 2025 - Template for Reports Developed B-1 Appendix A. Methods A.1 Search Strategies PubMed search strategy ((("cereal fiber"[tiab:~2] OR "cereal fibers" OR "cereal fibre"[tiab:~2] OR "cereal fibres" OR ((cereal OR edible OR whole) AND grain*) OR "soluble fiber*" OR "soluble fibre*" OR "insoluble fiber*" OR "insolubl…
  9. effectivehealthcare-admin.ahrq.gov/products/hepatitis-c-treatment-adherence/research-protocol
    December 01, 2019 - interventions in improving intermediate (e.g., sustained viral response, histological changes, drug resistance … sustained viral response (SVR), histological response, biochemical response (i.e., ALT level), drug resistance … We will record authors’ definitions about SVR, drug resistance, histological response, and quality of … response Early viral response Sustained viral response Disease relapse Development of any viral resistance … interventions in improving intermediate (e.g. sustained viral response, histological changes, drug resistance
  10. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
    January 01, 2007 - Angiotensin II acts directly on the resistance vessels to increase systemic vascular resistance and arterial
  11. effectivehealthcare-admin.ahrq.gov/products/hepatitis-c-screening/research
    December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
    September 13, 2012 - Promotion of antibiotic resistance c. Systemic absorption (rare) 3. … Promotion of antibiotic resistance f. Selection of resistant organisms 4. … Adverse effects of treatment (KQs 1, 2, & 3) Antibiotic-specific Hypersensitivity Antibiotic resistance … high bioavailability GI intolerance; increased risk for C. diff; prolonged exposure can result in resistance … hypersensitivity reactions, drug toxicity, Clostridium difficile diarrhea, promotion of antibiotic resistance
  13. effectivehealthcare-admin.ahrq.gov/products/depression-treatment-ssri/research-protocol
    December 01, 2019 - TF populations may include patients who would meet criteria for treatment resistance ( > 2 inadequate … Treatment resistance is variably defined but usually refers to patients who have failed at least two … classified as having treatment resistant depression. 7 Similarly, there is the potential for pseudo-resistance
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/c-diff-infections_disposition-comments.pdf
    March 01, 2012 - In the introduction no discussion was given regarding review of strategies to improving patient's resistance … Text was added to elaborate on strategies to improve resistance. … is a plausible biological mechanism to suggest that vancomycin therapy for CDAD may not select for resistance … do the authors mean by “resistant,” are they referring to in vitro the clindamycin and quinolone resistance … or is there actual evidence of resistance to the treating antibiotics or more that there is increased
  15. effectivehealthcare-admin.ahrq.gov/products/antipsychotics-adults/research
    December 01, 2019 - Subgroups The most common subgroups were race and treatment resistance.
  16. effectivehealthcare-admin.ahrq.gov/products/procalcitonin/research
    December 01, 2019 - high interest for future research are the consequences of reduction in antibiotic use for antibiotic resistance
  17. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/11_peptic_ulcer_potential_high_impact_2012-12-111.pdf
    January 01, 2012 - PEPTIC ULCER #11 AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 11: Peptic Ulcer Disease and Dyspepsia Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 ww…
  18. effectivehealthcare-admin.ahrq.gov/products/venous-ulcers-treatment/research-protocol
    December 01, 2019 - Hypersensitivity, contact dermatitis, and sensitization (e.g., neomycin) Promotion of antibiotic resistance … peripherally inserted central catheter (PICC) line and access infections Promotion of antibiotic resistance … high bioavailability GI intolerance; increased risk for C. diff; prolonged exposure can result in resistance … contained in dressings: hypersensitivity, contact dermatitis, sensitization, promotion of antibiotic resistance … hypersensitivity reactions, drug toxicity, Clostridium difficile diarrhea, promotion of antibiotic resistance
  19. effectivehealthcare-admin.ahrq.gov/products/hypertension-pulmonary-arterial/research-protocol
    December 01, 2019 - pathological changes of the pulmonary microcirculation that lead to an increase in pulmonary vascular resistance … been found to contribute to changes in the pulmonary vasculature, causing increased pulmonary vascular resistance … This increased resistance, if unrelieved, progresses to right ventricular pressure overload, dysfunction … outcomes beyond pulmonary artery pressure to include hemodynamic parameters (e.g., pulmonary vascular resistance … Hemodynamic parameters such as pulmonary artery pressures (systolic, diastolic, and mean), vascular resistance
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/depression-treatment-ssri_research-protocol.pdf
    June 15, 2010 - TF populations may include patients who would meet criteria for treatment resistance (> 2 inadequate … Treatment resistance is variably defined but usually refers to patients who have failed at least http … classified as having treatment resistant depression.7 Similarly, there is the potential for pseudo-resistance

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: